Protein Summary
Constitutive NADPH oxidase which generates superoxide intracellularly upon formation of a complex with CYBA/p22phox. Regulates signaling cascades probably through phosphatases inhibition. May function as an oxygen sensor regulating the KCNK3/TASK-1 potassium channel and HIF1A activity. May regulate insulin signaling cascade. May play a role in apoptosis, bone resorption and lipolysaccharide-mediated activation of NFKB. May produce superoxide in the nucleus and play a role in regulating gene expression upon cell stimulation. Isoform 3 is not functional. Isoform 5 and isoform 6 display reduced activity. Isoform 4: Involved in redox signaling in vascular cells. Constitutively and NADPH-dependently generates reactive oxygen species (ROS). Modulates the nuclear activation of ERK1/2 and the ELK1 transcription factor, and is capable of inducing nuclear DNA damage. Displays an increased activity relative to isoform 1. This gene encodes a member of the NOX-family of enzymes that functions as th ...more
- ENST00000263317
- ENSP00000263317
- ENSG00000086991
- ENST00000343727
- ENSP00000344747
- ENST00000375979
- ENSP00000365146
- ENST00000393282
- ENSP00000376961
- ENST00000424319
- ENSP00000412446
- ENST00000527956
- ENSP00000433797
- ENST00000529343
- ENSP00000435474
- ENST00000531342
- ENSP00000435039
- ENST00000532825
- ENSP00000434924
- ENST00000534731
- ENSP00000436892
- RENOX
- KOX
- KOX-1
- RENOX
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 0.99 | ||
cellular component | 0.93 | ||
protein domain | 0.85 | ||
molecular function | 0.81 | ||
disease | 0.78 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1439.65 (req: < 5)
Gene RIFs: 353 (req: <= 3)
Antibodies: 574 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1439.65 (req: >= 5)
Gene RIFs: 353 (req: > 3)
Antibodies: 574 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 38
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 83
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1